Latham & Watkins Advises Enko in its US$70 Million Series C Financing

Enko, the crop health company, has announced a US$70 million Series C funding round, bringing the company's overall capital raised to date to US$140 million. Global agrochemical company Nufarm led the round as part of an expanded partnership to bring innovative products to their core markets.

Latham & Watkins LLP represents Enko in the financing with a Boston-based corporate team led by partners Kristen Grannis and Spencer Ricks, with associate Andrew Rondeau.